2015
DOI: 10.1016/j.tracli.2015.03.005
|View full text |Cite
|
Sign up to set email alerts
|

Transfusion et inflammation : hier – aujourd’hui – demain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 89 publications
0
1
0
Order By: Relevance
“…anticoagulant or residual plasma) (3); residual leukocytes that carry HLA antigens, and in rare cases unexpected residual cells, such as platelets in red blood cells products (15). Leukocytes carry most of the antigenic load in a blood unit, yet the systematic use of leukoreduction process implemented in the late 90's to fight against Creutzfeldt-Jakob disease transmission dramatically reduced the amount of WBC into blood units (16,17). As a consequence, the rate of post-transfusion HLA sensitization decreased from nearly 30% of transfused patients to 10-20% depending on studies (18)(19)(20)(21).…”
Section: Discussionmentioning
confidence: 99%
“…anticoagulant or residual plasma) (3); residual leukocytes that carry HLA antigens, and in rare cases unexpected residual cells, such as platelets in red blood cells products (15). Leukocytes carry most of the antigenic load in a blood unit, yet the systematic use of leukoreduction process implemented in the late 90's to fight against Creutzfeldt-Jakob disease transmission dramatically reduced the amount of WBC into blood units (16,17). As a consequence, the rate of post-transfusion HLA sensitization decreased from nearly 30% of transfused patients to 10-20% depending on studies (18)(19)(20)(21).…”
Section: Discussionmentioning
confidence: 99%